SCHEMBL17870853

SCHEMBL17870853

CCCCN1CCC/C(C(=O)O)=C\c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 2/20 0.44
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
CHRM2 P08172 10/20 0.39
CHRM4 P08173 10/20 0.39
CHRM1 P11229 10/20 0.39
CHRM3 P20309 10/20 0.39
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
GAA P10253 1/20 0.38
CASP1 P29466 1/20 0.38
HTT P42858 1/20 0.38
CASP7 P55210 1/20 0.38
SMAD3 P84022 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19747069 1.00 MEN1 (0.44) MEN1KMT2AALDH1A1DRD2DRD4
SCHEMBL17870863 0.82 PIK3CD (0.42) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL17870841 0.82 PIK3CD (0.42) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL5545260 0.80 TNKS (0.44) MEN1KMT2AALDH1A1CHRM2CHRM4
SCHEMBL5545264 0.80 TNKS (0.44) MEN1KMT2AALDH1A1CHRM2CHRM4
SCHEMBL19746550 0.78 CCR5 (0.45) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL6516854 0.76 KMT2A (0.46) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL6516859 0.76 KMT2A (0.46) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL19748971 0.76 CCR5 (0.46) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL17870854 0.75 CCR5 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3471718-A1 PURIFIED CENICRIVIROC AND PURIFIED INTERMEDIATES FOR MAKING CENICRIVIROC Tobira Therapeutics, Inc. (US) 2019-04-24 EP claimed
WO-2017223155-A1 PURIFIED CENICRIVIROC AND PURIFIED INTERMEDIATES FOR MAKING CENICRIVIROC TOBIRA THERAPEUTICS, INC. (US) 2017-12-28 WO claimed
EP-3237424-A1 PROCESS OF MAKING CENICRIVIROC AND RELATED ANALOGS Tobira Therapeutics, Inc. (US) 2017-11-01 EP claimed
WO-2016105527-A1 PROCESS OF MAKING CENICRIVIROC AND RELATED ANALOGS TOBIRA THERAPEUTICS, INC. (US) 2016-06-30 WO claimed
EP-3237424-A1 PROCESS OF MAKING CENICRIVIROC AND RELATED ANALOGS Tobira Therapeutics, Inc. (US) 2017-11-01 EP disclosed
WO-2016105527-A1 PROCESS OF MAKING CENICRIVIROC AND RELATED ANALOGS TOBIRA THERAPEUTICS, INC. (US) 2016-06-30 WO disclosed